FDA flags issues at Coherus partner’s China manufacturing site for cancer drug
- Stock Market Stocks to buy Stocks to sell
admin
- 0
- 1 minute read
Coherus BioSciences Inc said on Wednesday that the U.S. Food and Drug Administration (FDA) flagged three observations at its partner Shanghai Junshi Biosciences Ltd’s manufacturing site in China for its investigational cancer drug.
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1116617012-6a8112931e6f4375b6e1481b39eeeae8.jpg "How to Become a Real Estate Agent: A Step-by-Step Guide")
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1255077848-13fe034d27ba4d1398930d76d7be6693.jpg "6 Best Paying Jobs in Finance")
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1246195248-4209faa3f1854e648d38836ebd402e96.jpg "Forex Market Sentiment Indicators and How To Use Them")